JYNT vs UTHR · P/E 92, rev $30.0M vs P/E 20, rev $1.56B
The Joint Corp (JYNT) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
The Joint Corp (JYNT) is a medical care facilities company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported JYNT revenue for 2026-06-30 was $30.0M. Net income was $2.0M. JYNT currently screens at market cap $117.9M and trailing P/E 91.9.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
JYNT currently screens at market cap $117.9M and trailing P/E 91.9. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the JYNT and UTHR stock pages for the full models.
Not investment advice.